Skip to main content
Caplight Logo









Strategikon Pharma

Strategikon Pharma

Private
San Francisco, CaliforniaEnterprise Softwarehttps://clinicalmaestro.com/

Last Round

Debt

Jun 10, 2025

Total Funding Raised

$7.03M

Company Overview

Strategikon Pharma is a software company that provides a cloud-based platform, Clinical Maestro, for clinical trial budgeting, sourcing, and outsourcing management.

Sector

Enterprise Software

Verticals

Clinical Trials, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial managementCTMSclinical trial budgetingcontract research organizationCROclinical outsourcingcontract lifecycle managementCLMclinical trial softwareeSourcevendor managementpharma techclinical operationsbiotech softwarefinancial forecastingvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Strategikon Pharma Comparables

Compare Strategikon Pharma with similar companies based on industry and business-model similarity.

Strategikon Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Auxilius
86%
Ledger Run
86%
ClinAI
84%

Strategikon Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJun 10, 2025
Series A ExtensionFeb 6, 2024
GrantApr 13, 2023
Series AApr 22, 2021
SeedJan 1, 2020

Key People

Founding team and executive leadership

Paulo Carvalho

Founder and COO

Founding Team

Anca Copaescu

Chief Executive Officer

Executive Team

Strategikon Pharma Investors

Notable investors and investment history

Strategikon Pharma investors
InvestorRounds
Saratoga VenturesSeed
Osage Venture PartnersSeries A, Series A Extension
Decathlon Capital PartnersDebt
Bascom VenturesSeries A
Wing Venture CapitalSeries A
Arizona Commerce AuthorityGrant
TCA Venture GroupSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 27, 2025

    Launched Clinical Maestro 5.0, an upgrade to its trial management solution.

  • Feb 6, 2024

    $7M round led by Osage Venture Partners.

Strategikon Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Strategikon Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Strategikon Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range33
Year Founded2017
Last FundingJun 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.